Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

Hepatology

Volumn 32, Issue 3, 2000, Pages 635-639

  Honkoop, Pieter ^a   De Man, Robert A ^a   Niesters, Hubert G M ^a   Zondervan, Pieter E ^a   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG WITHDRAWAL; HEPATITIS B; HUMAN; INCIDENCE; JAUNDICE; PRIORITY JOURNAL; RECURRENT INFECTION; RETREATMENT; SEROCONVERSION; VIRUS MUTANT;

EID: 0033839986     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.16333     Document Type: Article

References (38)

1. Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patients
2. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study
3. The role of delta superinfection in acute exacerbations of chronic type B hepatitis
4. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis
5. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection
6. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis
7. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis
8. Spontaneous reactivation of chronic hepatitis B virus infection
9. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis
10. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B
11. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
12. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
13. Glucocorticoid stimulates hepatitis B viral gene expression in cultured hepatoma cells
14. Natural history, of hepatitis-associated antigen-positive chronic liver disease
15. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
16. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection
17. Subacute and chronic active hepatitis after withdrawal of chemotherapy
18. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B INTERPRED Trial Group
19. Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)
20. Hepatitis B reactivation after lamivudine
21. A preliminary trial of lamivudine for chronic hepatitis B infection
22. Lamivudine therapy for chronic hepatitis B: A six months randomized dose ranging study
23. On behalf of an International Lamivudine Study Group. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial
24. Lamivudine as initial treatment for chronic hepatitis B in the United States
25. Lamivudine and lamivudine/interferon combination therapy in patients with hepatitis B who previously failed interferon: An international controlled trial
26. Analysis of Phase III controlled data regarding serum ALT elevations, during and following lamivudine treatment of hepatitis B patients
27. Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis
28. Serology of acute exacerbation in chronic hepatitis B virus infection
29. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations
30. Pattern and duration of HBV DNA seropositivity in acute hepatitis B
31. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection
32. Distinguishing between acute and symptomatic chronic hepatitis B virus infection
33. Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep)
34. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
35. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
36. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
37. Lamivudine resistance in immunocompetent chronic hepatitis B: Incidence and patterns
38. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy